ARS Pharmaceuticals, Inc. (SPRY)
2.96
-0.40
(-11.90%)
USD |
NASDAQ |
Nov 20, 16:00
2.95
-0.01
(-0.34%)
After-Hours: 20:00
ARS Pharmaceuticals Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 29, 2026 | 34.97 |
| September 28, 2026 | 32.82 |
| September 25, 2026 | 32.42 |
| September 24, 2026 | 32.98 |
| September 23, 2026 | 33.22 |
| September 22, 2026 | 35.60 |
| September 21, 2026 | 34.57 |
| September 18, 2026 | 32.66 |
| September 17, 2026 | 32.98 |
| September 16, 2026 | 33.10 |
| September 15, 2026 | 33.78 |
| September 14, 2026 | 35.76 |
| September 11, 2026 | 37.83 |
| September 10, 2026 | 40.21 |
| September 09, 2026 | 41.56 |
| September 08, 2026 | 42.84 |
| September 04, 2026 | 44.66 |
| September 03, 2026 | 45.06 |
| September 02, 2026 | 46.25 |
| September 01, 2026 | 45.86 |
| August 31, 2026 | 47.68 |
| August 28, 2026 | 46.81 |
| August 27, 2026 | 47.92 |
| August 26, 2026 | 47.92 |
| August 25, 2026 | 45.46 |
| Date | Value |
|---|---|
| August 24, 2026 | 42.52 |
| August 21, 2026 | 43.75 |
| August 20, 2026 | 43.75 |
| August 19, 2026 | 50.70 |
| August 18, 2026 | 50.07 |
| August 17, 2026 | 49.59 |
| August 14, 2026 | 44.90 |
| August 13, 2026 | 48.48 |
| August 12, 2026 | 48.08 |
| August 11, 2026 | 47.29 |
| August 10, 2026 | 46.97 |
| August 07, 2026 | 48.95 |
| August 06, 2026 | 44.11 |
| August 05, 2026 | 42.60 |
| August 04, 2026 | 42.28 |
| August 03, 2026 | 43.39 |
| July 31, 2026 | 40.77 |
| July 30, 2026 | 44.74 |
| July 29, 2026 | 46.33 |
| July 28, 2026 | 45.06 |
| July 27, 2026 | 45.78 |
| July 24, 2026 | 47.21 |
| July 23, 2026 | 47.68 |
| July 22, 2026 | 48.16 |
| July 21, 2026 | 50.54 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Capricor Therapeutics, Inc. | 2.104 |
| Sionna Therapeutics, Inc. | 0.5311 |
| Ardelyx, Inc. | 4.575 |
| Compass Therapeutics, Inc. | 0.8693 |
| ACADIA Pharmaceuticals, Inc. | 2.131 |
Price to Book Value Related Metrics
| PS Ratio | 2.408 |
| PEG Ratio | -0.0099 |
| Price | 2.96 |
| Earnings Yield | -67.99% |
| Market Cap | 296.74M |
| PEGY Ratio | -0.0099 |